Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

VA researchers shine light on the dangerous mental health consequences of COVID-19

VA researchers shine light on the dangerous mental health consequences of COVID-19

The ability of therapeutic monoclonal antibodies to neutralize SARS-CoV-2 Omicron BA.2 variant

The ability of therapeutic monoclonal antibodies to neutralize SARS-CoV-2 Omicron BA.2 variant

Demonstrating effectiveness of BNT162b2 vaccine in preventing reinfections after COVID-19 recovery

Demonstrating effectiveness of BNT162b2 vaccine in preventing reinfections after COVID-19 recovery

Meta-analysis of population-based seroprevalence studies to estimate SARS-CoV-2 seroprevalence in Africa

Meta-analysis of population-based seroprevalence studies to estimate SARS-CoV-2 seroprevalence in Africa

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV

Study explores efficacy of mRNA vaccine booster doses during the SARS-CoV-2 Omicron wave

Study explores efficacy of mRNA vaccine booster doses during the SARS-CoV-2 Omicron wave

Impact of several ACE2 coding missense variants and their effect on ACE2 protein subcellular localization and trafficking

Impact of several ACE2 coding missense variants and their effect on ACE2 protein subcellular localization and trafficking

Changes in the brain cortex of COVID-19 patients associated with inflammatory biomarkers

Changes in the brain cortex of COVID-19 patients associated with inflammatory biomarkers

Immunogenicity, efficacy, and safety of BNT162b2 or mRNA1273 fourth dose

Immunogenicity, efficacy, and safety of BNT162b2 or mRNA1273 fourth dose

mRNA vaccine-induced antibodies shown to be more effective in neutralizing SARS-CoV-2 and its variants than natural immunity

mRNA vaccine-induced antibodies shown to be more effective in neutralizing SARS-CoV-2 and its variants than natural immunity

‘I just want to stay in one spot’: From homeless to housed in rugged Del Norte

‘I just want to stay in one spot’: From homeless to housed in rugged Del Norte

As covid slogs on, seniors find fortitude waning and malaise growing

As covid slogs on, seniors find fortitude waning and malaise growing

Study shows mink can be infected by Omicron and efficiently transmit the virus to other mink

Study shows mink can be infected by Omicron and efficiently transmit the virus to other mink

Role of quantitative, multiplexed, targeted proteomics in determining variant-specific SARS-CoV-2 antibody response

Role of quantitative, multiplexed, targeted proteomics in determining variant-specific SARS-CoV-2 antibody response

Study finds antigenic profile of Omicron RBD is distinct from the prior SARS-CoV-2 variants of concern

Study finds antigenic profile of Omicron RBD is distinct from the prior SARS-CoV-2 variants of concern

COVID test-to-return may help shorten time away from school

COVID test-to-return may help shorten time away from school

Study finds 'substantial decrease' in people's mental wellbeing since the start of the pandemic

Study finds 'substantial decrease' in people's mental wellbeing since the start of the pandemic

How accurate are rapid antigen COVID tests?

How accurate are rapid antigen COVID tests?

Trial of early antiviral therapy for COVID-19 shows no significant benefit

Trial of early antiviral therapy for COVID-19 shows no significant benefit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.